Adjunctive and novel therapies for sepsis.
J Pediatr Intensive Care
; 3(4): 255-267, 2014 Dec.
Article
in En
| MEDLINE
| ID: mdl-31214472
ABSTRACT
Primary goals of sepsis therapy include early, appropriate antimicrobial therapy and prompt recognition and reversal of shock. Despite these measures, however, sepsis remains an important source of pediatric morbidity and mortality. Here we review rationale and existing evidence in support of adjunctive sepsis therapies including extracorporeal support, immunomodulation, and mitochondria-targeted therapies. While each of these therapeutic modalities shows promise, additional studies are urgently needed to identify the right patients, the right timing, and the right context for these interventions.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Pediatr Intensive Care
Year:
2014
Document type:
Article
Affiliation country: